It can be, but it requires significantly more medical supervision than for people without diabetes
Location: Plainsboro, New JerseyWarning Letter Date: September 9, 2025FDA Department Issuing Warning: Center for Drug Evaluation and Research (CDER)Type of Warning: False & Misleading Claims/Misbranded DrugsSubject of Violation: An Oprah Special: Shame, Blame, and the Weight Loss Revolution, regarding Wegovy (semaglutide) injection, for subcutaneous use, Ozempic (semaglutide) injection, for subcutaneous use, and Victoza (liraglutide) injection, for subcutaneous use.FDA Warning: In the program, which aired on television in 2024 and until recently was available continuously on the ABC website and through various streaming services, Novo Nordisk promoted Wegovy, Ozempic, and Victoza in a manner that failed to present the serious risks of these drug products in a truthful and nonmisleading manner
As for side effects, she said her patients dont usually report many
Through the vagina and cervix, a hysteroscope allows surgeons to remove or destroy fibroids without abdominal incisions, making them ideal for smaller, accessible fibroids and usually requiring only a short recovery
Microbial Ecol (2020) 80(4):90819
The 2.5 mg dose is for initiation, but the remaining doses can be used for chronic weight management